• No results found

Cover Page The handle http://hdl.handle.net/1887/138667

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle http://hdl.handle.net/1887/138667"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/138667 holds various files of this Leiden University dissertation.

Author: Kerkhof, M.

Title: Antiepileptic and antitumor treatment in brain tumor patients: Impact on clinical

and radiological treatment

(2)

ANTIEPILEPTIC AND

ANTITUMOR TREATMENT

IN BRAIN TUMOR PATIENTS:

IMPACT ON CLINICAL AND

RADIOLOGICAL OUTCOME

MELISSA KERKHOF

ANTIEPILEPTIC AND ANTITUMOR TREA TMENT IN BR AIN TUMOR P ATIENT S: IMP A C T ON CLINIC AL AND R ADIOL OGIC AL OUT COME MELISSA KERKHOF

Referenties

GERELATEERDE DOCUMENTEN

Part II focuses on the impact of antitumor treatment on clinical and radiological outcomes, with a specific focus on the differentiation between tumor progression versus

12, 29 As seizures in brain tumor patients are known to be often treatment resistant for medical therapy with AEDs, synergistic activity by anticonvulsant combination

Participants were recruited from January 2014 until May 2016 from the outpatient clinic in three large tertiary referral centers for brain tumor patients in the Netherlands:

Finally, the neuroradiologists gave an overall conclusion on tumor status based on the post-contrast T1- and T2-weighted images of MR1, MR2 and MR3, in combination with the

• Dynamic susceptibility-weighted contrast-enhanced (DSC) perfusion MRI is capable of quantifying vessel bloodvolume by assessment of the relative cerebral blood volume

responses of metastases were categorized into four groups based on changes in contrast enhancement on T1-weighted images during followup or based on a histologically

The goal of this thesis was to provide guidance for the neuro-oncologist’s daily clinical practice with respect to tailoring antiepileptic drug (AED) treatment and improving the

Deel I van dit proefschrift richtte zich op de rol van de epilepsie behandeling bij glioom patiënten in relatie tot klinische uitkomstmaten zoals overleving en de gevolgen van